免疫チェックポイント阻害剤で治療された再発性および/ または転移性頭頸部状細胞がん患者の臨床結果に対するサルコペニアの予後効果
Takayuki Kimura1, Daisuke Abe1, Mutsukazu Kitano1
1Department of Otolaryngology-Head and Neck Surgery, Kindai University, Faculty of Medicine, Osaka-Sayama, Japan.
Cancer diagnosis & prognosis
|September 3, 2025
まとめ
サルコペニア,または筋肉の喪失は,免疫チェックポイント阻害剤を投与された頭頸がん患者で,より悪い結果と関連しています. サルコペニアの治療は,再発性および転移性頭頸部状細胞癌の治療効果を向上させる可能性があります.
科学分野:
- 腫瘍学
- 免疫療法
- 臨床栄養について
背景:
- サルコペニアは栄養不良によって引き起こされ,頭頸部状細胞癌 (HNSCC) のアウトカムを悪化させる.
- 免疫チェックポイント阻害剤 (ICI) で治療された再発性/転移性HNSCC患者のサルコペニーの影響は不明である.
研究 の 目的:
- ICI治療を受けている再発性/転移性HNSCC患者におけるサルコペニアと臨床結果の関連性を調査する.
主な方法:
- ICI治療を受けた再発性/転移性HNSCC患者119人の遡及レビュー.
- サルコペニア状態に関連した客観的な応答率 (ORR),全生存率 (OS),免疫関連有害事象 (irAEs) の分析.
主要な成果:
- サルコペニア患者 (30. 7%) と非サルコペニア患者 (p=0. 048) のORRは低かった.
- サルコペニアと局域的な再発は,OSの独立した陰性予後因子であった.
- グループ間では有意な差異はありません.
結論:
- サルコペニアは,再発性/転移性HNSCCにおけるICI治療の有効性に悪影響を及ぼします.
- HNSCC患者の臨床管理では,サルコペニアの状態を考慮する必要があります.
関連する概念動画
Cancer Survival Analysis
448
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
448
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Tumor Immunotherapy
659
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
659


